G. Cavallaro, “Impact of the Addition of Daratumumab to the Standard Bortezomib-Thalidomide-Dexamethasone Regimen on Hematopoietic Stem Cell Mobilization and Collection, Post-Transplant Engraftment and Infectious Complications: A Case-Control Multicentre Real-Life Analy”, Mediterr J Hematol Infect Dis, vol. 16, no. 1, p. e2024049, Apr. 2024.